Market-Moving News for September 18th

Alaunos Therapeutics (TCRT) filed a patent application for the identification of neoantigen-reactive T cell receptors, causing its stock to rise by 69%. DataMeds AI (MEDS) settled litigation related to outstanding debt and receivables, retiring approximately 364,099 shares and paying $450,000 in cash, resulting in a 24% increase in its stock price. Conversely, Xenon Pharmaceuticals (XENE) saw a 26% decline in its stock after announcing a temporary pause in the enrollment of new patients in ongoing psychiatry studies.